ALLMedicine™ Inflammatory Bowel Disease Center
Research & Reviews 30,729 results
https://doi.org/10.1007/s10620-021-06888-5 10.1097/mog.0b013e32816aa392 10.3748/wjg.v20.i5.1165 10.1007/s00423-012-1030-9 10.1111/j.1572-0241.1999.01444.x 10.1038/ajg.2009.664 10.3748/wjg.v19.i43.7544 10.1136/gutjnl-2011-300695 10.1053/j.gastro.2017.05.056 10.1053/j.gastro.2014.10.010 10.1007/s11894-018-0639-4 10.1016/j.cgh.2012.05.018 10.1016/j.cgh.2014.12.032 10.1016/j.cgh.2019.07.032 10.1016/j.cgh.2012.05.018 10.1056/NEJM198712243172603 10.1016/s0016-5107(04)01878-4 10.1111/j.1572-0241.2001.04682.x 10.1093/ibd/izaa045
Digestive Diseases and Sciences; Basil M, Schwartz D et. al.
Feb 27th, 2021 - While the pathogenesis of inflammatory bowel disease (IBD) is incompletely understood, disruption of epithelial integrity is suspected to play a prominent role in disease initiation and progression. Currently, there is no convenient way to measure...
https://doi.org/10.1016/j.radonc.2021.02.026
Radiotherapy and Oncology : Journal of the European Socie... Bresolin A, Faiella A et. al.
Feb 27th, 2021 - To assess bowel dose-volume relationships for acute patient-reported intestinal symptoms of patients treated with whole-pelvis intensity-modulated radiotherapy (WPRT) for prostate cancer. Complete data of 415 patients enrolled in a multi institute...
https://doi.org/10.1016/j.intimp.2021.107482
International Immunopharmacology; Wu B, Wu Y et. al.
Feb 27th, 2021 - Heme is an important iron-containing porphyrin molecule expressed ubiquitously in organisms. Recently, this endogenous molecule has been widely reported to be involved in the pathogenesis of numerous diseases such as sepsis, atherosclerosis and in...
https://doi.org/10.1007/s10620-021-06895-6 10.1038/ajg.2015.233 10.1053/j.gastro.2013.07.041 10.1007/s11605-016-3275-z 10.1038/ajg.2017.394 10.1097/DCR.0000000000000975 10.1053/j.gastro.2018.04.012 10.1046/j.1524-475x.2000.00547.x 10.1136/gutjnl-2018-316772 10.1111/apt.12313 10.1111/apt.15184 10.1093/ibd/izaa020 10.1093/ibd/izy246 10.1038/nrgastro.2016.158 10.1016/j.cgh.2011.07.016 10.1136/bmjopen-2012-000823 10.1136/bmj.39345.714039.55 10.1053/j.gastro.2015.06.001 10.1371/journal.pmed.1000097 10.1136/bmj.d5928 10.1186/1471-2288-14-45 10.1002/sim.1761 10.1136/bmj.327.7414.557 10.1002/sim.2380 10.1136/bmj.39489.470347.AD 10.1136/bmj.328.7454.1490 10.1177/1536867X1501500203 10.1053/j.gastro.2005.03.003 10.1111/codi.13929 10.1111/j.1365-2036.2004.01904.x 10.1093/ecco-jcc/jjz129 10.1097/SLA.0000000000002017 10.1038/ajg.2016.541 10.1097/DCR.0b013e31829f682c 10.1159/000437362 10.1097/MCG.0b013e3182677003 10.1016/j.crohns.2011.08.014 10.1111/j.1463-1318.2010.02469.x 10.3109/00365521.2012.660540 10.1007/s11605-010-1385-6 10.1097/DCR.0b013e3182a0e702 10.1007/s10620-016-4400-2 10.1097/DCR.0b013e3182759029 10.1001/jamasurg.2017.1538 10.1007/s11605-008-0630-8 10.1111/apt.14459 10.1097/DCR.0000000000001482 10.1002/bjs.9439 10.1007/s11605-010-1341-5 10.1097/01.MIB.0000437497.07181.05 10.1007/s00384-018-3212-6 10.1111/j.1463-1318.2010.02186.x 10.1007/s00384-011-1236-2 10.1093/jcag/gwy013 10.1007/s11605-016-3194-z 10.1038/ajg.2012.464 10.1007/s00384-019-03481-1 10.1111/codi.13937 10.1038/ajg.2017.201 10.1111/j.1365-2036.2009.04204.x 10.1002/ibd.22954 10.1016/j.crohns.2013.01.014 10.1093/ecco-jcc/jjz087 10.1177/1756284820937089 10.4174/jkss.2012.83.3.141 10.1016/j.amjsurg.2012.10.014 10.1097/SLA.0000000000000757 10.1016/S0016-5085(19)36987-2 10.1093/ibd/izy156 10.1016/j.arth.2013.07.011 10.1093/ecco-jcc/jjy148
Digestive Diseases and Sciences; Hanzel J, Almradi A et. al.
Feb 26th, 2021 - Postoperative complication rates in patients with inflammatory bowel disease (IBD) receiving preoperative biologics have been analyzed without considering the surgical context. Emergency surgery may be associated with an increased risk of infectio...
https://www.ncbi.nlm.nih.gov/pubmed/33635221
Clinical and Experimental Rheumatology; Farisoğulları B, Yardımcı GK et. al.
Feb 26th, 2021 - To compare enteropathic spondylitis (ES) with psoriatic spondylitis (PS) and ankylosing spondylitis (AS), in patients on biological disease-modifying anti-rheumatic drug (bDMARD) treatment. Patients who were enrolled in the HUR-BIO registry were i...
Guidelines 137 results
https://doi.org/10.1016/j.cgh.2021.02.014
Clinical Gastroenterology and Hepatology : the Official C... Liang PS, Shaukat A et. al.
Feb 13th, 2021 - The purpose of this expert review is to describe the role of medications for the chemoprevention of colorectal neoplasia. Neoplasia is defined as precancerous lesions (e.g., adenoma and sessile serrated lesion) or cancer. The scope of this review ...
https://doi.org/10.1111/jdv.16926
Journal of the European Academy of Dermatology and Venere... Nast A, Smith C et. al.
Feb 6th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665406
Journal of Crohn's & Colitis; Ng SC, Mak JWY et. al.
Oct 21st, 2020 - Endoscopy is an essential component in the management of inflammatory bowel disease [IBD]. There is a risk of SARS-CoV-2 transmission during endoscopic procedures. The International Organization for the study of IBD [IOIBD] has developed 11 positi...
https://doi.org/10.1053/j.gastro.2020.08.060
Gastroenterology Ananthakrishnan AN, Nguyen GC et. al.
Oct 4th, 2020 - AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review.|2020|Ananthakrishnan AN,Nguyen GC,Bernstein CN,|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543377
Journal of Crohn's & Colitis; Dotan I, Panaccione R et. al.
Sep 22nd, 2020 - Infusion centres are a central part in the management of patients with inflammatory bowel disease [IBD] and could be a source of transmission of SARS-COV-2. Here we aimed to develop global guidance for best practices of infusion centres for IBD pa...
Drugs 55 results see all →
Clinicaltrials.gov 31,959 results
https://doi.org/10.1007/s10620-021-06888-5 10.1097/mog.0b013e32816aa392 10.3748/wjg.v20.i5.1165 10.1007/s00423-012-1030-9 10.1111/j.1572-0241.1999.01444.x 10.1038/ajg.2009.664 10.3748/wjg.v19.i43.7544 10.1136/gutjnl-2011-300695 10.1053/j.gastro.2017.05.056 10.1053/j.gastro.2014.10.010 10.1007/s11894-018-0639-4 10.1016/j.cgh.2012.05.018 10.1016/j.cgh.2014.12.032 10.1016/j.cgh.2019.07.032 10.1016/j.cgh.2012.05.018 10.1056/NEJM198712243172603 10.1016/s0016-5107(04)01878-4 10.1111/j.1572-0241.2001.04682.x 10.1093/ibd/izaa045
Digestive Diseases and Sciences; Basil M, Schwartz D et. al.
Feb 27th, 2021 - While the pathogenesis of inflammatory bowel disease (IBD) is incompletely understood, disruption of epithelial integrity is suspected to play a prominent role in disease initiation and progression. Currently, there is no convenient way to measure...
https://doi.org/10.1016/j.radonc.2021.02.026
Radiotherapy and Oncology : Journal of the European Socie... Bresolin A, Faiella A et. al.
Feb 27th, 2021 - To assess bowel dose-volume relationships for acute patient-reported intestinal symptoms of patients treated with whole-pelvis intensity-modulated radiotherapy (WPRT) for prostate cancer. Complete data of 415 patients enrolled in a multi institute...
https://doi.org/10.1016/j.intimp.2021.107482
International Immunopharmacology; Wu B, Wu Y et. al.
Feb 27th, 2021 - Heme is an important iron-containing porphyrin molecule expressed ubiquitously in organisms. Recently, this endogenous molecule has been widely reported to be involved in the pathogenesis of numerous diseases such as sepsis, atherosclerosis and in...
https://doi.org/10.1007/s10620-021-06895-6 10.1038/ajg.2015.233 10.1053/j.gastro.2013.07.041 10.1007/s11605-016-3275-z 10.1038/ajg.2017.394 10.1097/DCR.0000000000000975 10.1053/j.gastro.2018.04.012 10.1046/j.1524-475x.2000.00547.x 10.1136/gutjnl-2018-316772 10.1111/apt.12313 10.1111/apt.15184 10.1093/ibd/izaa020 10.1093/ibd/izy246 10.1038/nrgastro.2016.158 10.1016/j.cgh.2011.07.016 10.1136/bmjopen-2012-000823 10.1136/bmj.39345.714039.55 10.1053/j.gastro.2015.06.001 10.1371/journal.pmed.1000097 10.1136/bmj.d5928 10.1186/1471-2288-14-45 10.1002/sim.1761 10.1136/bmj.327.7414.557 10.1002/sim.2380 10.1136/bmj.39489.470347.AD 10.1136/bmj.328.7454.1490 10.1177/1536867X1501500203 10.1053/j.gastro.2005.03.003 10.1111/codi.13929 10.1111/j.1365-2036.2004.01904.x 10.1093/ecco-jcc/jjz129 10.1097/SLA.0000000000002017 10.1038/ajg.2016.541 10.1097/DCR.0b013e31829f682c 10.1159/000437362 10.1097/MCG.0b013e3182677003 10.1016/j.crohns.2011.08.014 10.1111/j.1463-1318.2010.02469.x 10.3109/00365521.2012.660540 10.1007/s11605-010-1385-6 10.1097/DCR.0b013e3182a0e702 10.1007/s10620-016-4400-2 10.1097/DCR.0b013e3182759029 10.1001/jamasurg.2017.1538 10.1007/s11605-008-0630-8 10.1111/apt.14459 10.1097/DCR.0000000000001482 10.1002/bjs.9439 10.1007/s11605-010-1341-5 10.1097/01.MIB.0000437497.07181.05 10.1007/s00384-018-3212-6 10.1111/j.1463-1318.2010.02186.x 10.1007/s00384-011-1236-2 10.1093/jcag/gwy013 10.1007/s11605-016-3194-z 10.1038/ajg.2012.464 10.1007/s00384-019-03481-1 10.1111/codi.13937 10.1038/ajg.2017.201 10.1111/j.1365-2036.2009.04204.x 10.1002/ibd.22954 10.1016/j.crohns.2013.01.014 10.1093/ecco-jcc/jjz087 10.1177/1756284820937089 10.4174/jkss.2012.83.3.141 10.1016/j.amjsurg.2012.10.014 10.1097/SLA.0000000000000757 10.1016/S0016-5085(19)36987-2 10.1093/ibd/izy156 10.1016/j.arth.2013.07.011 10.1093/ecco-jcc/jjy148
Digestive Diseases and Sciences; Hanzel J, Almradi A et. al.
Feb 26th, 2021 - Postoperative complication rates in patients with inflammatory bowel disease (IBD) receiving preoperative biologics have been analyzed without considering the surgical context. Emergency surgery may be associated with an increased risk of infectio...
https://www.ncbi.nlm.nih.gov/pubmed/33635221
Clinical and Experimental Rheumatology; Farisoğulları B, Yardımcı GK et. al.
Feb 26th, 2021 - To compare enteropathic spondylitis (ES) with psoriatic spondylitis (PS) and ankylosing spondylitis (AS), in patients on biological disease-modifying anti-rheumatic drug (bDMARD) treatment. Patients who were enrolled in the HUR-BIO registry were i...
News 1,731 results
https://www.medscape.com/viewarticle/946169
Feb 21st, 2021 - NEW YORK (Reuters Health) - A subset of macrophages, PTGER4+ (EP4+), are the major drivers of epithelial regeneration after intestinal inflammation and are potential targets for inflammatory bowel disease (IBD) therapy, researchers say. "Dysfuncti...
https://www.medscape.com/viewarticle/946043
Feb 18th, 2021 - NEW YORK (Reuters Health) - The monoclonal antibody ustekinumab (Stelara, Janssen) appears to be at least as effective against ulcerative colitis (UC) in real-world practice as it was in the clinical trials that led to its approval, according to n...
https://www.medscape.com/viewarticle/945979
Feb 16th, 2021 - Patients with advanced melanoma and preexisting autoimmune diseases (AIDs) who were treated with immune checkpoint inhibitors (ICIs) responded well and did not suffer more grade 3 or higher immune-related adverse events than patients without an AI...
https://www.medscape.com/viewarticle/945801
Feb 15th, 2021 - (Reuters Health) - Children with Hirschsprung disease may be at increased risk for developing inflammatory bowel disease, a Canadian study suggests. Researchers examined data on 716 children diagnosed with Hirschsprung since 1991 in Ontario, as we...
https://www.medscape.com/viewarticle/945729
Feb 11th, 2021 - A large analysis of Medicare data from all 50 states suggests that vedolizumab may be just as effective as anti–tumor necrosis factor (anti-TNF) agents in controlling inflammatory bowel disease (IBD) in patients aged over 65 years, with fewer infe...